Tender

CPAP, BiPAP, NIV, Sleep Therapy Devices and Associated Products

HEALTHTRUST EUROPE LLP (HTE) ACTING AS AGENT FOR THE UNIVERSITY HOSPITALS OF COVENTRY AND WARWICKSHIRE NHS TRUST (“UHCW”)

This public procurement record has 1 release in its history.

TenderUpdate

16 Mar 2021 at 22:56

Summary of the contracting process

The procurement process titled "CPAP, BiPAP, NIV, Sleep Therapy Devices and Associated Products" is being conducted by HealthTrust Europe LLP, acting for the University Hospitals of Coventry and Warwickshire NHS Trust. This tender falls under the medical devices industry category, specifically classified as medical breathing devices (CPV code: 33157400). The current stage of procurement is in the Tender phase, with the authority having modified the maximum number of suppliers for the framework agreement from 6 to up to 12 suppliers for various lots. Key updates regarding this tender were published on 16 March 2021, noting the increased demand stemming from the Covid-19 pandemic.

This tender presents significant opportunities for businesses in the medical supplies sector, particularly those specialising in respiratory devices and associated products. Companies that can efficiently respond to high-volume demands and manage supply chain pressures will be well-positioned to compete. The intention to increase the number of suppliers for the framework agreement will foster greater competition and is aimed at ensuring that the needs of the health sector are met adequately, thereby offering a potential avenue for growth for both established firms and new entrants in the market.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

CPAP, BiPAP, NIV, Sleep Therapy Devices and Associated Products

Notice Description

CPAP, BiPAP, NIV, Sleep Therapy Devices and Associated Products

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-029c5f
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/005358-2021
Current Stage
Tender
All Stages
Tender

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Not Specified
Procurement Method Details
Not specified
Tender Suitability
Not specified
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33157400 - Medical breathing devices

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
16 Mar 20214 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Not Specified
Lots Status
Not Specified
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
HEALTHTRUST EUROPE LLP (HTE) ACTING AS AGENT FOR THE UNIVERSITY HOSPITALS OF COVENTRY AND WARWICKSHIRE NHS TRUST (“UHCW”)
Contact Name
Not specified
Contact Email
claude.lewis@healthtrusteurope.com
Contact Phone
+44 08458875000

Buyer Location

Locality
EDGBASTON, BIRMINGHAM
Postcode
B15 1NU
Post Town
Birmingham
Country
England

Major Region (ITL 1)
TLG West Midlands (England)
Basic Region (ITL 2)
TLG3 West Midlands
Small Region (ITL 3)
TLG31 Birmingham
Delivery Location
Not specified

Local Authority
Birmingham
Electoral Ward
Edgbaston
Westminster Constituency
Birmingham Edgbaston

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-029c5f-2021-03-16T22:56:03Z",
    "date": "2021-03-16T22:56:03Z",
    "ocid": "ocds-h6vhtk-029c5f",
    "initiationType": "tender",
    "tender": {
        "id": "ocds-h6vhtk-029c5f",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "CPAP, BiPAP, NIV, Sleep Therapy Devices and Associated Products",
        "classification": {
            "scheme": "CPV",
            "id": "33157400",
            "description": "Medical breathing devices"
        },
        "mainProcurementCategory": "goods",
        "description": "CPAP, BiPAP, NIV, Sleep Therapy Devices and Associated Products",
        "amendments": [
            {
                "id": "1",
                "unstructuredChanges": [
                    {
                        "oldValue": {
                            "text": "Envisaged maximum number if participants to the framework agreement = 6"
                        },
                        "newValue": {
                            "text": "Envisaged maximum number if participants to the framework agreement = 11"
                        },
                        "where": {
                            "section": "IV.1.3",
                            "label": "Envisaged maximum number of participants to the framework agreement"
                        }
                    }
                ],
                "description": "(i) We propose to conclude a framework agreement (FA) with a number of providers all of whom responded to the call for competition set out in the Contract Notice -2020/S 153 - 375968 and whose tenders were compliant. Those bidders are identified in Section V. (ii) The range of services/supplies that are in scope remains unchanged. The number and contents of the Lots remains unchanged. The advertised award procedure was followed and the award criteria remain unchanged. The only change is set out in clause (iii) below. (iii) This notice is to inform the market that we intend to increase the number of economic operators to be appointed to Lots 1, 2, 3, and 4 of the FA. This will mean that for Lot 1 the number of appointees will be 11 rather than 6; for Lot 2 the number of appointees will be 7 rather than 6; for Lot 3 the number of appointees will be 7 rather than 6; and for Lot 4 the number of appointees will be 12 rather than 6. The name and contact details (postal address) of each supplier to be appointed per lot can be found in Section V. (iv) The need for this modification has been brought about as a result of a marked increase in demand and significant pressures being faced by suppliers and their supply chains as a consequence of the Covid 19 pandemic. These are circumstances which the contracting authority, acting diligently, could not have foreseen. The modification will increase the number of suppliers to whom customers can gain access, thereby increasing competition and reducing the risk that demand for these products cannot be met under the framework. (v) We consider that the change is permitted under Part 2 of the Public Contracts Regulations 2015 (as amended) and Directive 2014/24/EC without the need for a new procurement. (vi) We have considered whether a new call for competition should be published. The modification does not alter the overall nature of the framework agreement. The estimated total value of the FA remains unchanged from that advertised. We therefore consider that the authority is entitled to rely on regulation 72 (1) (c) of the PCR 2015. (vii) We also consider that the change is not \"substantial\" within the meaning of regulation 72 (8) of the PCR 2015 (as amended) and Directive 2014/24, in particular, that it does not alter the scope of the FA; does not make it materially different in character and would not have attracted additional participants because of the nature of the market and the very high number of operators who expressed an interest and submitted tenders. (viii) We will not conclude the FA for a period of 10 days beginning with the date after this notice is published in OJEU. The following changes are what will take place, in light of the above: Lot 1: The previous envisaged maximum number of participants to the framework agreement = 6 The new envisaged maximum number of participants to the framework agreement = 11 Lot 2: The previous envisaged maximum number of participants to the framework agreement = 6 The new envisaged maximum number of participants to the framework agreement = 7 Lot 3: The previous envisaged maximum number of participants to the framework agreement = 6 The new envisaged maximum number of participants to the framework agreement = 7 Lot 4: The previous envisaged maximum number of participants to the framework agreement = 6 The new envisaged maximum number of participants to the framework agreement = 12"
            }
        ]
    },
    "parties": [
        {
            "id": "GB-FTS-1597",
            "name": "HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust (\"UHCW\")",
            "identifier": {
                "legalName": "HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust (\"UHCW\")"
            },
            "address": {
                "streetAddress": "19 George Road",
                "locality": "Edgbaston, Birmingham",
                "region": "UK",
                "postalCode": "B15 1NU",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "telephone": "+44 08458875000",
                "email": "claude.lewis@healthtrusteurope.com"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://healthtrusteurope.bravosolution.co.uk"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-1597",
        "name": "HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust (\"UHCW\")"
    },
    "links": [
        {
            "rel": "prev",
            "href": "https://ted.europa.eu/udl?uri=TED:NOTICE:375968-2020:TEXT:EN:HTML"
        }
    ],
    "language": "en"
}